CliffBio
small molecule

CEFAZOLIN IN DEXTROSE

CEFAZOLIN SODIUM

Loss of exclusivity—loss of exclusivity
CompanyBaxter Healthcare Corp →See this company's full patent-cliff portfolio

Drug detail

Brand nameCEFAZOLIN IN DEXTROSE
Active ingredientCEFAZOLIN SODIUM
StrengthEQ 1GM BASE/50ML (EQ 20MG BASE/ML)
Dosage formSOLUTION
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalFebruary 2021
Marketing statusRX

More from Baxter Healthcare Corp

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.